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SUMMARY 
Progress report of a program involving bone marrow transplantation in the 
treatment of radiation sickness in mice and monkeys. 
Results are provided on fetal hemopoietic grafts in monkeys, selective 
elimination of immunologically active cells in the graft, the pooling of bone 
marrow from different donors, the modification of secondary disease following 
foreign bone marrow transplantation, the prevention of secondary disease, 
the selection of compatible donors and fundamental work on tissue trans-
plantation. 
The report also contains a description of the progress achieved in the field 
of production and evaluation of pathogen free animals and gnotobionts in 
radiation research. 
BONE MARROW TRANSPLANTATION IN IRRADIATED ANIMALS 
PRODUCTION AND APPLICATION OF PATHOGEN FREE ANIMALS 
IN RADIATION EXPERIMENTS *) 
1 — BONE MARROW TRANSPLANTATION IN IRRADIATED ANIMALS 
Experiments with monkeys 
1.1 — X-disease 
In 1962 an outbreak of a chronic disease occurred in the monkey colony, which soon affected 
the majority of the animals. The disease was characterized by hyperkeratosis, alopecia and 
wasting and run a slow course with a mortality of nearly 100 per cent. In the course of 1963 
the disease was identified with a disease termed X-disease which has been described in young 
cattle, where it is due to the toxic effects of halogenated naphtalenes. The source of the toxic 
substance in the monkey colony was found to be sawdust, which was employed as an absorbant 
in the pans underneath the cages and which was consumed in small quantities by most monkeys. 
This sawdust is routinely steam sterilized before use. This use of sawdust was therefore discon-
tinued and since that time no new cases of the disease have occurred spontaneously. 
Experiments aimed at the isolation and identification of the toxic substance in the sawdust 
were continued during 1964. It was found that the sawdust becomes toxic as a result of the 
steam sterilization. Although chemical analyses of the sawdust demonstrated the presence of a 
high content of pentachlorophenol, the feeding or application of this substance did not induce 
the disease. However long continued feeding of a concentrated extract of autoclaved sawdust 
did produce mild symptoms of X-disease. In this stage of the investigation it was concluded that 
a further research on this subject fell outside the terms of the contract. 
The costs of additional experiments to identify the toxic substance will be carried com-
pletely by the Radiobiological Institute. Autoclaving of sawdust is being increasingly employed 
for its use in specific pathogen free rodent colonies, so that the resumption of toxic by-products 
seems to be of more general significance. 
1.2 — Fetal hemopoietic grafts 
A considerable number of fetuses became available from the breeding colony. Hemo-
poietic cells from the liver of fetuses at the age of around 100 days were used for the restoration 
of lethally irradiated monkeys. It was soon found that the yield of cells from a fetus at that age 
(0.3 — 1 X 109) is insufficient to cause repopulation of the recipient's hemopoietic tissues, so 
that it became necessary to pool the cells of several fetuses of the same age. This in turn necessita-
ted the synchronization of pregnancies. A total of 5 experiments was performed with pooled 
fetal cells administered in numbers varying between 7 and 11 X 108 per kg body weight of the 
recipient. Regeneration of the hemopoiesis was observed only in the animal which received the 
highest cell dose. This animal developed secondary disease from which it succumbed 34 days 
*) Manuscript received on July 15, 1965. 
after transplantation. The other animals showed some temporarily regeneration at best and all 
died with bone marrow aplasia. These experiments are being continued with fresh as well as 
with stored cells as fetal material becomes available. 
1.3 — Storage of hemopoietic cells at low temperatures 
The investigations on the freezing and storage of autologous monkey bone marrow have 
been completed. Using the polyvinylpyrollidone-glycerol mixture to protect the cells during 
freezing, a total number of 15 irradiated monkeys has been treated with various numbers of 
preserved autologous cells. The minimum number of cells required for recovery was found to be 
8 X 107/kg as compared to 4 χ 107/kg in the case of fresh autologous bone marrow cells. This 
yields a preservation factor of 50 % under optimal conditions. 
Freezing and storage with 10 % polyvinylpyrollidone which proved to give excellent 
protection to mouse bone marrow, was found to give disappointing results with monkey bone 
marrow. These results have again underlined the large differences between rodent and primate 
bone marrow. It is concluded that clinical bone marrow preservation methods should preferably 
be tested in monkeys. The polyvinylpyrollidone-glycerol procedure is recommended for clinical 
application since it was found to be the most effective technique in experiments with monkeys. 
The investigation of freezing methods for use with fetal monkey liver cell suspensions 
are being continued on a limited scale. 
1.4 — Pretreatment of the bone marrow graft 
In mice several procedures of pretreating the homologous bone marrow have been found 
to result in a selective elimination of immunologically active cells, thereby causing a decreased 
incidence of secondary mortality in the recipients. Two of these procedures — freezing with 
glycerol and incubation at 37 °C for several hours — were investigated in pilot experiments with 
monkeys. The results were not encouraging. The best survival time (obtained following treatment 
with the frozen marrow) was 42 days but this animal died with overt signs of secondary disease. 
The experiments with monkeys were discontinued, awaiting the discovery of more effective 
methods in the mouse system. 
1.5 — Pooled bone marrow 
The experiments with pooled homologous bone marrow which were initiated in 1963, 
were completed. Table I shows that the number of pooled cells required to produce complete 
bone marrow regeneration is far greater than in the case of a single donor (2 χ 108/kg). Following 
administration of the lower cell numbers bone marrow regeneration is poor and as a consequence 
secondary disease is much less pronounced. At least 109 pooled cells/kg seem to be required for 
adequate restoration of hemopoiesis but in these cases the usual lethal secondary disease ensues. 
These results do not support the impression obtained from very limited clinical experience 
that pooling of homologous bone marrow decreases the risk of the development of secondary 
disease to a considerable extent. 
1.6 — Chemical treatment of secondary disease 
A systematic study has been made of the effects of treatment with methotrexate after 
the transplantation of homologous bone marrow in irradiated monkeys. Treatment with this 
drug has been found to be effective in mice in preventing secondary mortality by other investi-
gators. In the monkeys doses of 1/4 - 4 mg/day have been employed starting on days 1-10 follow­
ing the bone marrow transplantation. Supportive treatment is attempted with parenteral fluids, 
blood transfusions and diets. The dosage schedules investigated so far were not effective in 
significantly prolonging survival but the experiments are being continued. 
TABLE I 
Treatment of irradiated monkeys with pooled bone marrow suspensions 
Radiation dose 750 - 800 R (700 - 750 rad) 
No. of 
cells/kg 
3.4 χ 108 
6.1 χ 108 
7.3 χ 108 
1.3 x 109 




































1.7 — Selection of compatible donors 
In the fields of bone marrow and organ transplantation it has become increasingly impor­
tant to find the least incompatible host-donor combination. Blood group compatibility has generally 
been found to be of little significance. The finding of common antigens in leukocytes and nucleated 
cells from the tissues has stimulated attempts to type or group leukocytes in humans. Attempts 
are being made in several centres to demonstrate a parallelism between patterns of leukocyte 
antigens and of transplantation antigens, so as to enable recognition of comparative histo­
compatibility in humans. 
Experiments along those lines have been initiated in 1964 with monkeys because they 
seem to be a suitable "second best" in such research. Many striking similarities have been observed 
between the reactions of patients and monkeys to homologous bone marrow transplantation 
after irradiation. It is expected that a significant decrease of the severity of secondary disease 
will be obtained when the degree of histoincompatibility between donor and host is diminished 
by selection. 
Iso-antisera were produced by immunization of monkeys with skin grafts or blood from 
other monkeys. These antisera were strong enough to be used for the identification by aggluti­
nation of certain antigens on the leukocytes. By thus recording the antigen-pattern of the donor 
cells the take of an homologous bone marrow can be demonstrated. 
For the recognition of relative histocompatibility however monospecific antisera of 
sufficient strength are required. Attempts are being made to produce these sera by absorbtion 
procedures and modifications of the technique of immunization. 
A method of skin grafting suitable for monkeys was developed to use as an additional 
criterium in the evaluation of the degree of histocompatibility between individuals. 
1.8 — Preirradiation sanitation of monkeys 
A small number of baboons was studied with regard to suitability for radiation and bone 
marrow transplantation experiments. These animals were also heavily contaminated with 
strongyloides and did not seem to offer any advantages over the rhesus monkeys used thus far. 
At the time of writing a small group of Macacus speciosa monkeys is under investigation. 
The treatment of oesophagostomum infections with Alcopar *) yielded satisfactory 
results. Trials are in progress with a new drug : Thiabendazole **), which seems to be superior. 
Bone marrow transplantation in irradiated mice 
1.9 — Specific immunological tolerance of the graft in radiation chimeras 
In continuation of studies reported in the previous years investigations have been per-
formed on the role of the thymus in the development of immunity and of specific tolerance in 
radiation chimeras. In the absence of the thymus the return of anti-third party activity is greatly 
prolonged but — depending on the host-donor combination used — some restoration of this 
function was eventually observed. In these cases the graft remained tolerant towards the host, 
from which it was concluded that the thymus is not wholly essential for the development of 
specific immunological tolerance. 
Attempts have been initiated to characterize the factors in the thymus which are res-
ponsible for restoration of normal immunological reactivity in radiation chimeras by the use of 
diffusion chambers containing fragments of the thymus of newborn mice. So far implantation 
of such chambers remained without significant effects. The suitability of the diffusion chambers 
for this type of experiment is being investigated. 
The distribution of labeled hemopoietic cells in normal and thymectomized animals has 
been studied with autoradiographic techniques. No evidence of a passage of these cells through 
the thymus following whole body irradiation and hemopoietic cell transplantation was obtained. 
The latter investigations have been concluded. 
Studies on the persistence of immunological tolerance following transfer of tolerant cells 
into irradiated hosts have been continued. In addition to the role of the thymus in the main-
tainance of tolerance, the effects of variations on the numbers of passaged bone marrow cells 
have been investigated. It has been concluded that maintainance of tolerance within a lymphatic 
cell population is independent of an antigen excess and that loss of tolerance within an intact 
organism is due to replacement of the original tolerant lymphatic cell population by new cells 
derived from bone marrow precursor cells. The latter replacement requires the presence of the 
thymus. The capacity of the bone marrow in radiation chimeras to supply these precursor cells 
is dependent on the number of cells injected into the first host. 
1.10 — Immunological techniques 
A semi-quantitative test was developed to measure the antibody synthesis of individual 
cells of the lymphatic tissues in vitro. Lymphoid cell suspensions derived from animals immunized 
with sheep erythrocytes were employed. The possibility of using the test system for the detection 
of other antibodies by employing antigen-coated sheep erythrocytes is being investigated. 
*) (2-(4'-thiazolyl)-benzimidazole) 
**) benzyldimethyl-(/3-phenoxyethyl) ammonium embónate 
1.11 — Factors influencing the proliferation of foreign bone mar row cells in irradiated 
hosts 
The acute killing effect of homologous lymphoid cells in irradiated animals has been stu-
died in relation to the number of bone marrow cells transplanted simultaneously. 
The proliferative capacity of hemopoietic cells derived from radiation chimeras was found 
to be different from that of normal hemopoietic cells in that the capacity to repopulate the lym-
phatic tissues of irradiated (second) recipients was permanently impaired. This change was 
dependent on the number of bone marrow cells used to restore the first host. 
A comparative study of the repopulation of the hemopoietic tissues in mice following 
partial body irradiation and whole body irradiation plus isologous bone marrow transplantation 
was made : three different techniques were employed. Survival of irradiated mice, rate of repo-
pulation of the hemopoietic tissues and the colony formation in spleen. Injected hemopoietic 
cells were consistently found to be much more effective (by a factor of the order of 100) than cells 
shielded in situ. These experiments are being concluded. 
1.12 — Secondary disease 
The similarity between the post-thymectomy wasting syndrome and secondary disease 
following homologous or heterologous bone marrow transplantation in mice was confirmed by 
extensive histological studies of the two syndromes. In contrast to earlier observations by others 
it was found that the lymphatic atrophy which occurs in the thymectomized animals is of a secon-
dary nature rather than primary. The thymectomized animals develop in addition a number 
of lesions which are considered as highly characteristic for certain auto-immune diseases in 
humans. On the basis of these findings it has been postulated that the post-thymectomy wasting 
syndrome is the result of an auto-immune reaction which develops in the absence of the thymus 
during the neonatal period. Confirmation of this hypothesis has been sought by using a variety 
of serological and transplantation techniques. A large number of positive Coombs reactions 
have been found among wasting thymectomized C57BL mice but not among mice of other strains. 
The nature of the antibodies involved is under investigation. 
A comparison of the histopathological lesions of secondary disease, the post-thymectomy 
wasting syndrome and of NZB mice (which suffer from spontaneous auto-immune disease) is 
being made. In addition investigations are in progress concerning the presence of auto-immune 
factors in the secondary disease which develops under certain conditions following lethal irradia-
tion and isologous bone marrow transplantation. 
Experiments have been started with heterologous bone marrow transplantation into 
lethally irradiated germfree mice. The purpose of these investigations is to study the histopatho-
logical lesions accompanying secondary disease under germfree conditions to allow an evaluation 
of the contribution of infections to the syndrome. 
1.13 — Prevention of secondary disease 
A screening system was developed previously for the testing of methods aimed at the 
selective elimination of immunologically competent cells from suspensions in vitro. This system 
was used to investigate several new methods described by the group of Mathé. One consists of 
freezing and storage of the suspensions at low temperature. In our system there was some indica-
tion of selective elimination of immune cells but the effect was not impressive. The second proce-
dure consists of incubation of the suspension for 1 or 2 hours at 37 °C and this was found to be 
highly effective in some experiments. Unfortunately this effect was not reproducible. The causes 
of this variation are being investigated. 
1.14 — Treatment of secondary disease 
Several degrees of secondary disease can be reproducibly induced in Fi hybrid mice by 
whole body irradiation and the transplantation of mixtures of bone marrow and spleen from parent 
strain donors. 
In these mice various dosage schedules of methotrexate have been studied. The results 
will be compared with the effects of methotrexate on secondary disease in monkeys. It is intended 
to employ such a system for the evaluation of other immunosuppressive drugs with respect to 
their capacity to modify the severity of secondary disease. 
2 — PRODUCTION AND EXPERIMENTAL EVALUATION 
OF PATHOGEN FREE ANIMALS 
2.1 — Specific pathogen free rats 
A new SPF rat colony was started in the second half of 1964. This colony is being serviced 
by caretakers working in a plastic suit with air supply which provides a complete barrier between 
the personnel and the animals. The suit is desinfected on the outside before each entry into the 
colony. Rats from several inbred strains are derived by caesarian section, introduced aseptically 
into the colony building and fostered by gnotobiotic females that were kept previously in iso-
lators. The microflora of the rats in this protected colony is being consistently analyzed to 
provide information on the efficiency of the barrier system. Work is continuing on modifications 
and improvements of the personnel suits. 
2.2 — Gnotobionts 
Satisfactory progress has been made with the germfree mouse colony. Breeding of the 
ND2 mice was excellent and many animals were available for experimental use during this year. 
Small groups of germfree mice have been supplied to other laboratories in the Netherlands 
for the testing of their new germfree installations or for the establishment of an SPF mouse 
colony. Among these institutes were the Netherlands Cancer Institute, Amsterdam; the National 
Institute of Health, Utrecht, and the Laboratory Animal Farm TNO, Zeist. A group of gnoto-
biotic rats was supplied to the latter farm for the establishment of its SPF rat colony. 
The first attempts to introduce mice of the CBA and C57BL strains into the germfree 
state failed but recent trials have been more promising. 
Germfree rats obtained early in 1964 from elsewhere have failed to reproduce. Another 
nucleus of germfree rats will be acquired as soon as possible. 
2.3 — Enterobacteriaceae free mice 
A program has been started to produce and maintain mice which are completely free 
of Enterobacteria. These mice are required for the study of the effects of whole body neutron 
irradiation because such experiments are constantly disturbed by fatal septicemia caused by 
intestinal microorganisms e.g. proteus. Among the methods employed for the production of these 
mice are prolonged treatment with the antibiotic Kanamycin in a closed isolator system and 
contamination of germfree mice with a specified microflora in a less protected environment. 
8 
So far normal reproduction has occurred but several difficulties have been encountered 
in the raising of the young. Attempts are in progress to overcome these difficulties by modifications 
of the autoclaved diet. 
2.4 — Irradiation experiments 
Neutron and γ irradiations are being carried out with Enterobacteria free mice under 
continuous bacteriological supervision. The radiosensitivities of germfree and conventional mice 
have been compared. The results are in accordance with those obtained at Lobund Institute. 
The survival following doses of X irradiation above 1,200 rad is significantly prolonged in the 
germfree mice. The effect of bone marrow transplantation following these high doses of irra­
diation is under investigation. A detailed histological study is in progress of the tissues of normal 
and irradiated germfree mice with emphasis on the intestinal tract. 
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